Tech Company Financing Transactions
DocSpera Funding Round
Johnson & Johnson Innovation, Pier 70 Ventures and private investors participated in a $10 million Series B funding round for DocSpera. The round was announced by the company on 9/27/2022.
Transaction Overview
Company Name
Announced On
9/27/2022
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series B
Investors
Johnson & Johnson Innovation (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate commercialization of its existing suite of products as well as to invest in scaling the engineering, customer success and commercial teams to support their continued expansion.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
333 W El Camino Real, 370
Sunnyvale, CA 94087
USA
Sunnyvale, CA 94087
USA
Phone
Website
Email Address
Overview
DocSpera is a Silicon Valley-based tech company focused on helping physicians and their care team drive workflow efficiency and real-time collaboration across a patient's continuum of care. DocSpera's platform is designed to manage a patient from the surgical decision point through their end of recovery. The platform enables providers with tailored models based on AI to help digest thousands of data points, identify potential risks and improve seamless coordination.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Samuel Ethiopia
Co-Founder
Sy Fahimi
Co-Founder
Kenneth Trauner
Browse more venture capital transactions:
Prev: 9/27/2022: GlossGenius venture capital transaction
Next: 9/27/2022: Searchspring venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs